ערך בספרים למניה: Benitec Biopharma (BNTC)

Benitec Biopharma Inc. (BNTC) is an Australian biotech startup where experienced management relies on external funding and subsidies. The asset's market dynamics on the GURU.Markets platform show a value of 5.10. Benitec Biopharma Inc. (BNTC) generates revenue through partnerships and grants while developing gene silencing methods. However, relying exclusively on a single platform to combat dysphagia creates critical risks for investors.

Benitec Biopharma Inc. (BNTC) development of innovative gene silencing methods requires colossal resources to secure patents and navigate clinical trials. This metric is calculated as the difference between all assets and liabilities divided by the number of shares, reflecting the real value of an investor's stake; analyzing the historical change in book value per share allows for an assessment of the company's financial stability in the face of high technological risks.